Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

Middle East UCAV capabilities building up

David Oliver takes a look at the Middle East’s combat aerial vehicle capabilities.

Oman Air reaffirms support for MoSD’s initiatives

Oman Air has introduced a range of projects to ensure providing optimum support to families under social insurance families and those with special needs.

Aerotask places a McDonnell Douglas MD-83 for AMCON

Aerotask, a Dubai-based global aviation consultancy providing Asset Management and Financial Solutions to airlines, lessors, financiers and aviation investors worldwide, has successfully transacted a McDonnell Douglas MD-83

Qatar's Italian job

Qatar Airways’ now-finalised involvement in Meridiana – for many years Italy’s ‘second airline’ – will see the Italian airline adopt a new identity and potentially challenge beleaguered flag-carrier Alitalia. Alan Dron reports.

Pegasus relaunches its frequent flyer programme

Pegasus has relaunched its frequent flyer programme, ‘Pegasus BolBol.’

Turkish Aerospace hold workshop in Jakarta

Turkish Aerospace held a workshop on August 14, 2018 in Jakarta with an extensive participation of Indonesian Defence and Aviation Industry companies, regarding the possible cooperation on upcoming several bilateral opportunities

TAA SK0902311218
See us at
Istanbul Airshow BT22018MEBAA BT1004121218AIME19BTA3005120219MAPS18_BT1207131118GATM BT1004061118Cargo BT1004091018MarrakechAirshow BT2507241018ASDubai BT1004091018BIAS BT271017161118Aviation Africa BT0607280219